Articles & Issues
- Language
- English
- Conflict of Interest
- In relation to this article, we declare that there is no conflict of interest.
- Publication history
-
Received November 8, 2013
Accepted April 16, 2014
-
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © KIChE. All rights reserved.
All issues
Removal of potentioally genotoxic impurity from fluroxamine maleate crude drug by molecularly imprinted polymer
Department of Chemistry, Damghan Branch, Islamic Azad University, Damghan, Iran
Korean Journal of Chemical Engineering, October 2014, 31(10), 1898-1902(5), 10.1007/s11814-014-0110-7
Download PDF
Abstract
The present study describes the synthesis and preliminary testing of molecularly imprinted polymers (MIPs) as scavenger resins for removal of the genotoxic impurity (GTI) (2RS)-2-[[2-[[[(1E)-5-methoxy-1-[4(trifluoromethyl) phenyl] pentylidene] amino] oxy] ethyl] amino] butanedioic acid from active pharmaceutical ingredients (API). To compare the performance of this polymer, a control polymer or non-imprinted polymer (NIP) was prepared under the same conditions without the use of template molecule. The synthesized polymers were characterized by FT-IR spectroscopy. The results of the selectivity of the molecularly imprinted polymer for absorption GTI impurity through adsorption experiments reviews were compared with the adsorption of impurity by NIP. Various parameters were optimized, such as time, pH, type of eluent for elution of impurity from polymer, concentration of sample and saturation of polymer._x000D_
The proposed method was applied for removal of this genotoxic impurity from Fluvoxamine maleate tablet.
Keywords
References
FDA advisory committee recommends luvox (fluvoxamine) tablets for obsessive compulsive disorder, The Free Library, 1993 PR Newswire Association LLC 12 June (2014)
Figgitt DP, McClellan KJ, Drugs, 60, 4 (2000)
Stahl SM, Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications, Cambridge University Press (2013)
Wilkinson A, Courtney M, Westlind-Danielsson A, Hallnemo G, Akerman KE, J. Pharmacol. Exp. Ther., 271, 3 (1994)
Nicholson KL, Balster RL, Psychopharmacology, 170, 2 (2003)
Pharmacopoeia B A-290 4 (2007)
Fritz JS, Analytical solid-phase extraction, Wiley-Vch New York (1999)
Hennion MC, J. Chromatogr. A, 856, 1 (1999)
Pichon V, Chapuis-Hugon F, Anal. Chim. Acta, 622, 1 (2008)
Pichon V, J. Chromatogr. A, 1152, 1 (2007)
Mayes A, Whitcombe M, Adv. Drug Deliv. Rev., 57, 12 (2005)
Spivak DA, Adv. Drug Deliv. Rev., 57, 12 (2005)
Mei S, Wu D, Jiang M, Lu B, Lim JM, Zhou YK, Lee YI, Microchem. J., 98, 1 (2011)
Blomgren A, Berggren C, Holmberg A, Larsson F, Sellergren B, Ensing K, J. Chromatogr. A, 975, 1 (2002)
Song S, Shi X, Li R, Lin Z, Wu A, Zhang D, Process Biochem., 43, 11 (2008)
Okutucu B, Onal S, Talanta, 87 (2011)
Caro E, Marce RM, Cormack PA, Sherrington DC, Borrull F, J. Chromatogr. B, 813, 1 (2004)
Muldoon MT, Stanker LH, Anal. Chem., 69, 5 (1997)
Baggiani C, Giovannoli C, Anfossi L, Tozzi C, J. Chromatogr. A, 938, 1 (2001)
Song X, Li J, Xu S, Ying R, Ma J, Liao C, Liu D, Yu J, Chen L, Talanta, 99 (2012)
Chapuis F, Pichon V, Lanza F, Sellergren S, Hennion MC, J. Chromatogr. A, 999, 1 (2003)
Claude B, Morin P, Lafosse M, Belmont AS, Haupt K, Talanta, 75, 2 (2008)
Hu SG, Li L, He XW, J. Chromatogr. A, 1062, 1 (2005)
Baggiani C, Anfossi L, Giovannoli C, Anal. Chim. Acta, 591, 1 (2007)
Mahony J, Nolan K, Smyth M, Mizaikoff B, Anal. Chim. Acta, 534, 1 (2005)
Figgitt DP, McClellan KJ, Drugs, 60, 4 (2000)
Stahl SM, Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications, Cambridge University Press (2013)
Wilkinson A, Courtney M, Westlind-Danielsson A, Hallnemo G, Akerman KE, J. Pharmacol. Exp. Ther., 271, 3 (1994)
Nicholson KL, Balster RL, Psychopharmacology, 170, 2 (2003)
Pharmacopoeia B A-290 4 (2007)
Fritz JS, Analytical solid-phase extraction, Wiley-Vch New York (1999)
Hennion MC, J. Chromatogr. A, 856, 1 (1999)
Pichon V, Chapuis-Hugon F, Anal. Chim. Acta, 622, 1 (2008)
Pichon V, J. Chromatogr. A, 1152, 1 (2007)
Mayes A, Whitcombe M, Adv. Drug Deliv. Rev., 57, 12 (2005)
Spivak DA, Adv. Drug Deliv. Rev., 57, 12 (2005)
Mei S, Wu D, Jiang M, Lu B, Lim JM, Zhou YK, Lee YI, Microchem. J., 98, 1 (2011)
Blomgren A, Berggren C, Holmberg A, Larsson F, Sellergren B, Ensing K, J. Chromatogr. A, 975, 1 (2002)
Song S, Shi X, Li R, Lin Z, Wu A, Zhang D, Process Biochem., 43, 11 (2008)
Okutucu B, Onal S, Talanta, 87 (2011)
Caro E, Marce RM, Cormack PA, Sherrington DC, Borrull F, J. Chromatogr. B, 813, 1 (2004)
Muldoon MT, Stanker LH, Anal. Chem., 69, 5 (1997)
Baggiani C, Giovannoli C, Anfossi L, Tozzi C, J. Chromatogr. A, 938, 1 (2001)
Song X, Li J, Xu S, Ying R, Ma J, Liao C, Liu D, Yu J, Chen L, Talanta, 99 (2012)
Chapuis F, Pichon V, Lanza F, Sellergren S, Hennion MC, J. Chromatogr. A, 999, 1 (2003)
Claude B, Morin P, Lafosse M, Belmont AS, Haupt K, Talanta, 75, 2 (2008)
Hu SG, Li L, He XW, J. Chromatogr. A, 1062, 1 (2005)
Baggiani C, Anfossi L, Giovannoli C, Anal. Chim. Acta, 591, 1 (2007)
Mahony J, Nolan K, Smyth M, Mizaikoff B, Anal. Chim. Acta, 534, 1 (2005)
